AI-Powered Immune Phenotyping by Lunit SCOPE IO Marks First TKI-Resistant Lung Cancer Immunotherapy Success

Lunit SCOPE IO pivotal in first phase III trial successfully showing the efficacy of immunotherapy + chemotherapy for NSCLC patients with EGFR or ALK mut...

October 25, 2023 | Wednesday | News
Next-Gen Cologuard Test Outperforms FIT in Cancer Detection: BLUE-C Study Results

American College of Gastroenterology (ACG) gives BLUE-C study late breaker status at 2023 annual meeting with presentation of the only head-to-head study r...

October 23, 2023 | Monday | News
Thermo Fisher Partners with Boehringer Ingelheim on Companion Diagnostic for NSCLC Treatment

To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targete...

October 20, 2023 | Friday | News
Charles River Labs Offers Pediatric PDX Collection for Oncology Research Access

Charles River Laboratories International, Inc. announced the ability to conduct preclinical cancer research using ITCC-P4’s well-characterized collec...

October 17, 2023 | Tuesday | News
Baxter Launches Digital Image Capture Capability for PanOptic Plus Ophthalmoscope

Helps support faster diagnosis, enabling earlier treatment of eye conditions Enables a more digitally connected primary care exam Facilitates collabora...

October 17, 2023 | Tuesday | News
Astellas Receives Positive CHMP Opinion for VEOZA™ (fezolinetant)

Fezolinetant is an investigational nonhormonal treatment for vasomotor symptoms (VMS) associated with menopause More than half of women ages 40 to 64 wor...

October 16, 2023 | Monday | News
MHTC and Experts Unite to Spotlight Breast Cancer Awareness

In conjunction with breast cancer awareness month, the Malaysia Healthcare Travel Council (MHTC) together with Subang Jaya Medical Centre, organised a thou...

October 16, 2023 | Monday | News
FDA Clears Pfizer's BRAFTOVI® + MEKTOVI® for Lung Cancer with BRAF V600E Mutation

Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) fo...

October 13, 2023 | Friday | News
GE Healthcare Inks $44M Deal with BARDA for AI-Enhanced Ultrasound Tech to Boost Trauma Care and Disaster Preparedness

GE HealthCare (Nasdaq: GEHC) today announced it signed a $44 million contract with the Biomedical Advanced Research and Development Authority (BARDA)&mdash...

October 13, 2023 | Friday | News
Danaher Unveils a New Identity with a Singular Focus on Advancing Human Health through Science and Technology

Danaher's new motto is "Accelerating the Power of Science and Technology to Improve Human Health." The organization's renewed focus is on driving innovatio...

October 12, 2023 | Thursday | News
Hansa Biopharma announces encouraging high-level results for first-in-human trial of HNSA-5487

Hansa Biopharma, "Hansa", a pioneer in enzyme technology for rare immunological conditions,  announced high-level results from NICE-01, the first-in-h...

October 10, 2023 | Tuesday | News
Agilent Partners with Sarawak Infectious Disease Centre to Advance Research on Tropical Diseases in Malaysia

Agilent announced the signing of a Memorandum of Understanding (MOU) with the Sarawak Infectious Disease Centre (SIDC) in East Malaysia. The agreemen...

October 09, 2023 | Monday | News
Thermo Fisher Boosts St. Louis Biologic Manufacturing for Complex Treatments

Thermo Fisher Scientific, the world leader in serving science, today expanded its manufacturing capacity in St. Louis to support biologic therapies for dis...

October 09, 2023 | Monday | News
Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million

“Our ongoing partnership with Bayer leverages the full suite of our Twist Biopharma Solutions offering of antibody discovery services to identify the...

October 06, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close